Harpoon Therapeutics, Inc.

CIK 1708493 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Harpoon Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 21, 202415-12G0001193125-24-073818
Mar 18, 2024SC 13G0001076809-24-000080
Mar 13, 2024SC 13D/A0000807249-24-000032
Mar 11, 2024EFFECT9999999995-24-000639
Mar 11, 202440000950170-24-029445
Mar 11, 202440000950170-24-029433
Mar 11, 202440000950170-24-029165
Mar 11, 20248-K0001193125-24-064395
Mar 11, 2024POS AM0001193125-24-064463
Mar 11, 2024S-8 POS0001193125-24-064448
Mar 11, 202440000950170-24-029430
Mar 11, 202440000950170-24-029434
Mar 11, 202440000950170-24-029439
Mar 11, 2024SC 13D/A0001193125-24-064741
Mar 11, 2024S-8 POS0001193125-24-064446
Mar 11, 202440000950170-24-029429
Mar 11, 202425-NSE0001354457-24-000134
Mar 11, 202440000950170-24-029447
Mar 11, 2024S-8 POS0001193125-24-064449
Mar 11, 202440000950170-24-029443
Mar 11, 202440000950170-24-029446
Mar 11, 2024EFFECT9999999995-24-000638
Mar 11, 2024S-8 POS0001193125-24-064436
Mar 11, 202440000950170-24-029425
Mar 11, 2024S-8 POS0001193125-24-064457